Figure 1 | Scientific Reports

Figure 1

From: Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2

Figure 1

Inactivation testing workflow. SARS-CoV-2 suspensions are treated with guanidine-free molecular extraction reagents or LFIA buffers and mixed before incubating for the recommended contact time. If filtration is required to remove product-associated cytotoxicity, samples are added to a purification resin and centrifuged to elute and immediately titrated. If filtration steps are not required, samples are immediately titrated. Image created in Inkscape version 1.0 https://inkscape.org.

Back to article page